These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 7326663
1. Recent concepts on the mechanism of action of methotrexate. White JC. Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663 [No Abstract] [Full Text] [Related]
2. Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction. Goldman ID. Cancer Treat Rep; 1977 Jul; 61(4):549-58. PubMed ID: 884691 [No Abstract] [Full Text] [Related]
3. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro. Fabre G, Matherly LH, Fabre I, Cano JP, Goldman ID. Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419 [Abstract] [Full Text] [Related]
4. [Biochemistry of cytotoxicity of amethopterin (author's transl)]. Manteuffel-Cymborowska M. Postepy Biochem; 1978 Mar; 24(1):93-115. PubMed ID: 652668 [No Abstract] [Full Text] [Related]
11. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist. Skeel RT, Sawicki WL, Cashmore AR, Bertino JR. Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449 [No Abstract] [Full Text] [Related]
12. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. Fry DW, Anderson LA, Borst M, Goldman ID. Cancer Res; 1983 Mar; 43(3):1087-92. PubMed ID: 6186369 [No Abstract] [Full Text] [Related]
13. Studies on the effect of antifolics in mouse leukemia. Motycka K. Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901 [No Abstract] [Full Text] [Related]
14. Effects of 2,4-dinitrophenol and other metabolic inhibitors on the bidirectional carrier fluxes, net transport, and intracellular binding of methotrexate in Ehrlich ascites tumor cells. Fry DW, White JC, Goldman ID. Cancer Res; 1980 Oct; 40(10):3669-73. PubMed ID: 7438050 [No Abstract] [Full Text] [Related]
15. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells. Domin BA, Cheng YC, Hakala MT. Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960 [No Abstract] [Full Text] [Related]
16. Antifolates: in vivo kinetic considerations. Zaharko DS, Dedrick RL. Cancer Treat Rep; 1977 Jul; 61(4):513-8. PubMed ID: 301775 [Abstract] [Full Text] [Related]
17. Resistance mechanisms to methotrexate in tumors. Bertino JR, Göker E, Gorlick R, Li WW, Banerjee D. Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944 [Abstract] [Full Text] [Related]
19. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. Goldman ID. Biochim Biophys Acta; 1971 Jun 01; 233(3):624-34. PubMed ID: 5113921 [No Abstract] [Full Text] [Related]
20. The molecular perspective: methotrexate. Goodsell DS. Stem Cells; 1999 Jun 01; 17(5):314-5. PubMed ID: 10527466 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]